Vimarsana
Biggest News Aggregation in the World

Page 36 - Ischemic Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ischemic Stroke Today - Breaking & Trending Today

Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2 - Vimarsana News

Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2

In patients with acute ischemic stroke who have not received thrombolysis or thrombectomy, early versus late antihypertensive treatment did not reduce the likelihood of death and major disability.

Stroke patients with cognitive and emotional problems have higher risk of being more fatigued - Vimarsana News

Stroke patients with cognitive and emotional problems have higher risk of being more fatigued

Some people feel worse than others after a stroke. Stroke patients with cognitive and emotional problems tend to experience fatigue more often and sleep more during the day, according to recent research.

Novel Celery Seed–Derived Drug May Improve Stroke Outcomes - Vimarsana News

Novel Celery Seed–Derived Drug May Improve Stroke Outcomes

The drug, butylphthalide, was associated with better outcomes after ischemic stroke after thrombolysis or endovascular therapy.

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination - Vimarsana News

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

Researchers examined the factors associated with stroke following coronavirus disease 2019 (COVID-19) vaccination.

About 1 in 5 stroke survivors found to have irregular heart rhythms - Vimarsana News

About 1 in 5 stroke survivors found to have irregular heart rhythms

Irregular heart rhythms were detected in about 1 in 5 people who survived an ischemic stroke due to atherosclerosis (buildup of fatty substances in the arteries) after being continuously monitored for three years with an insertable cardiac device, according to preliminary late-breaking science presented at the American Stroke Association's International Stroke Conference 2023.